Clinical Trial Update: NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

View source ↗

Summary

This trial update reports the terminated evaluation of iptacopan for efficacy and safety in adults with paroxysmal nocturnal hemoglobinuria (NCT07036718).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Status: TERMINATED